Page 7 - Patrick Yu News Today

Positioning the Company as the Leader in the Outsourcing Cash Center BusinessNEW YORK, NY / ACCESSWIRE / November 30, 2021 / Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ:GFAI)(NASDAQ:GFAIW)

Press release content from Accesswire. The AP news staff was not involved in its creation.

Announces Merger with Guardforce AI Singapore Pte. Ltd.NEW YORK, NY / ACCESSWIRE / November 4, 2021 / Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ:GFAI)(NASDAQ:GFAIW), an integrated

The United States must focus on developing a positive vision for the future of its role in Africa rather than relying solely on criticizing China’s engagement on the continent.

Clinically meaningful difference between visual outcomes of LUMEVOQ®-treated patients and untreated patients Regulatory News: GenSight Biologics ...

SINGAPORE / ACCESSWIRE / May 26, 2021 / The global digital payment market is a structurally growing market. Recently, the importance and high growth of online channels have been adequately highlighted due to the impact of Covid-19.

Press release content from Business Wire. The AP news staff was not involved in its creation. GenSight Biologics Announces Publication of Results from the REALITY LHON Natural History Study in the Journal Eye May 3, 2021 GMT Figure 1. Evolution of BCVA in ND4-LHON patients aged ≥ 15 at onset of vision loss (Graphic: Business Wire) Figure 1. Evolution of BCVA in ND4-LHON patients aged ≥ 15 at onset of vision loss (Graphic: Business Wire) PARIS--(BUSINESS WIRE)--May 3, 2021-- Regulatory News:...

Patrick Yu "The fact that almost a third of the population describe themselves as racially prejudiced, almost half of young people have witnessed racist bullying in schools, and that these figures are rising not falling, suggests Stormonts racial equality strategy is failing," he said. Geraldine McGahey, Chief Commissioner at the Equality Commission, welcomed the report but added: "It is a concern that almost one in three people reported that they were prejudiced against people from minority et...

Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, today announced that the journal of the American Academy of Ophthalmology, Ophthalmology ® gene therapy in ND4 Leber Hereditary Optic Neuropathy (LHON) subjects. The paper*, published in the January issue under the title, �...

Experimental Therapy Injected in One Eye Unexpectedly Improves Vision in The Other 15 DECEMBER 2020 In a development that could restore sight to thousands of people with an inheritable condition called Lebers Hereditary Optic Neuropathy (LHON), scientists have been able to improve vision in both eyes in a majority of patients – even though only one eye was actually treated.   The treatment is an experimental type of gene therapy, where tailored genetic material is injected to counteract g...